Quant-Rated Healthcare and Communication Services Stocks: Post-Earnings Winners

The conclusion of the Q4 2025 earnings cycle has provided a definitive look at the winners and losers in the healthcare and communication services sectors, as reflected in Seeking Alpha’s proprietary quant ratings. For investors, these ratings serve as a data-driven filter, stripping away the noise of management guidance to focus on objective metrics: momentum, profitability, value, growth, and, perhaps most critically, earnings-per-share (EPS) revisions. In a market increasingly defined by quality growth, the divergence between the top and bottom deciles of these sectors has rarely been more pronounced.

In the healthcare space, the narrative remains dominated by the innovation gap. Companies that have successfully navigated the post-pandemic landscape by pivoting toward high-margin, high-demand therapeutic areas—most notably GLP-1 agonists and specialized biotechnology—are sweeping the top quant spots. Eli Lilly and Novo Nordisk continue to lead the pack, bolstered by relentless upward revisions to their earnings outlooks as manufacturing capacity for obesity treatments finally begins to meet global demand. Conversely, legacy pharmaceutical giants like Pfizer and Bristol Myers Squibb find themselves at the bottom of the quant rankings. These firms are grappling with the dual pressures of patent cliffs—the expiration of exclusivity for blockbuster drugs—and a lack of immediate catalysts to replace lost revenue. For these laggards, the quant Value grade may look attractive, but poor Momentum and Growth scores signal a potential value trap for investors expecting a quick turnaround.

“

The conclusion of the Q4 2025 earnings cycle has provided a definitive look at the winners and losers in the healthcare and communication services sectors, as reflected in Seeking Alpha’s proprietary quant ratings.

The communication services sector tells a similar story of technological bifurcation. The mega-cap leaders—Meta Platforms and Alphabet—have secured top quant ratings by demonstrating that artificial intelligence is no longer just a capital expenditure, but a tangible revenue driver. Meta, in particular, has seen its Profitability and Momentum grades surge as AI-driven ad targeting improves conversion rates for advertisers, leading to significant earnings beats and positive forward guidance. On the other end of the spectrum, traditional media and entertainment companies like Warner Bros. Discovery and Paramount Global continue to languish. These entities are trapped in a cycle of high debt and a streaming war that has yet to yield the consistent profitability investors demand. Their quant ratings are weighed down by negative EPS Revisions as analysts lower expectations for linear TV advertising and subscriber growth in an increasingly fragmented market.